Novel Cancer Therapeutics Summit 2013

We welcome you to GTC's 2nd Novel Cancer Therapeutics Summit taking place on February 25-26, 2013 in Las Vegas, NV. This summit brings together experts from academia and industry to discuss the emerging targets, therapeutics and strategies against cancer, as well as showcase ubiquitins' huge potential in the development of therapeutics. Attendees will also receive updates on government policy, recent regulations, important investments and partnering strategies.

2nd Novel Cancer Therapeutics Summit consists of three concurrent conferences shown below:

• 4th Cancer Targets & Therapeutics

• 2nd Oncology Partnering & Deal-making

• 3rd Ubiquitin Research & Drug Discovery

• Keynote Speaker

Aaron Ciechanover

Dedicated networking events have been incorporated to enhance the exchange of information between technology developers and end-users. The 2nd Novel Cancer Therapeutics Summit will provide a great opportunity for companies to expose products and services

Call for Papers!

To be considered for an oral presentation, please submit an abstract here by January 25, 2013. Selected presentations will be based on quality of abstract and availability. Presentation slots fill up fast so please submit your abstract ASAP.

Summit registration gives you access to all Three tracks!

Sponsorship and exhibiting opportunities are available in a range of levels, which can be tailored to fit your needs. Please contact 626-256-6405 x102 or gtcsales@gtcbio.com for more information